Actinogen Medical Limited (ASX:ACW)
Australia · Delayed Price · Currency is AUD 0.0470
0.00 (0.00%)
May 8, 2026, 3:59 PM AEST
Actinogen Medical Market Cap
Actinogen Medical has a market cap or net worth of 168.8 million as of May 8, 2026. Its market cap has increased by 89.75% in one year.
Market Cap
168.80M
Enterprise Value
162.49M
Revenue
7.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since October 16, 2007, Actinogen Medical's market cap has increased from 12.97M to 168.80M, an increase of 1,201.24%. That is a compound annual growth rate of 14.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 168.80M | -13.17% |
| Dec 31, 2025 | 194.40M | 148.21% |
| Dec 31, 2024 | 78.32M | 54.29% |
| Dec 29, 2023 | 50.76M | -71.90% |
| Dec 30, 2022 | 180.63M | -36.39% |
| Dec 31, 2021 | 283.98M | 832.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Starpharma Holdings | 307.44M |
| Tetratherix | 253.83M |
| Orthocell | 231.97M |
| Recce Pharmaceuticals | 146.04M |
| Nyrada | 135.95M |
| Dimerix | 123.08M |
| Alterity Therapeutics | 108.75M |
| Island Pharmaceuticals | 103.57M |